Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. 


https://www.cognitotx.com/

Cognito Therapeutics Group announced it raised $196 Million in an initial filing from an offering of $196 Million

Company Information

Related People

Funding Insights

Cognito Therapeutics Group announced it raised $196 Million in an initial filing from an offering of $196 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information